Fascination About pharma blogs
January 21, 2025 In 21 CFR 211.94 it is mentioned that “Drug products containers and closures shall not be reactive, additive, or absorptive to change the security, identity, power, good quality or purity with the drug outside of the Formal or established demands.” When the code makes this statement, and if expanded on from the relevant FDA Gui